ATYPICAL HEMOLYTIC UREMIC SYNDROME
Clinical trials for ATYPICAL HEMOLYTIC UREMIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL HEMOLYTIC UREMIC SYNDROME trials appear
Sign up with your email to follow new studies for ATYPICAL HEMOLYTIC UREMIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare Kidney-Blood disease: crovalimab trial shows promise
Disease control OngoingThis study tests a new medicine called crovalimab for people with a rare disease called atypical hemolytic uremic syndrome (aHUS), which causes blood clots and kidney damage. The trial includes 83 adults and teens who receive the drug to see if it can control the disease and impr…
Matched conditions: ATYPICAL HEMOLYTIC UREMIC SYNDROME
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with rare kidney disease: crovalimab trial underway
Disease control OngoingThis phase 3 trial tests crovalimab in 41 children with atypical hemolytic uremic syndrome (aHUS), a rare disease that causes blood clots and kidney damage. The drug is given first through a vein, then as a shot under the skin every four weeks. The goal is to see if it can stop d…
Matched conditions: ATYPICAL HEMOLYTIC UREMIC SYNDROME
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New tests could transform care for rare kidney diseases
Knowledge-focused OngoingThis study aims to develop better lab tests to diagnose and monitor two rare kidney diseases: atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G). Researchers will analyze blood, cells, and kidney tissue from 180 patients and healthy volunteers to find markers t…
Matched conditions: ATYPICAL HEMOLYTIC UREMIC SYNDROME
Phase: NA • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC